TOKYO, May 22 (Pulse News Wire) – Linical CO.,LTD. (2183.T) reported its order backlog stood at ¥130.15 billion as of May 22, marking a 10.9% increase compared to March 2025.
The company noted two pending contracts were finalized since May 15, contributing to the growth. Regionally, the breakdown showed Asia's backlog increased due to multiple new contract wins, while Japan saw a decline. In Europe, the backlog grew thanks to completed contracts for large international joint trials and strengthened collaboration with U.S.
Firms. The United States also experienced an uptick in orders, driven by several major international joint trials and new contracts. Notably, the company highlighted a surge in interest for global projects and continued efforts to enhance sales and proposals across regions.
🟢 Confidence: High AI-translated content.